Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 3Glioblastoma 3Neuroblastoma 2Lymphoma 2Carcinoma, Non-Small-Cell Lung 2Advanced Malignant Solid Tumor 2Thymoma 1Retinoblastoma 1Resectable Pancreatic Cancer 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Objective Response Rate 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Glioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1Advanced Refractory Solid Tumors 1

Interventions

130-nm albumin-bound paclitaxel 2selinexor 1pembrolizumab 1isophosphamide mustard 1epacadostat 1Sunitinib 1Ramucirumab 1Radiotherapy 1Radiation Dose Hypofractionation 1Paclitaxel 1Leucovorin 1Histocompatibility Testing 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Cyclophosphamide 1Cisplatin 1Chemoradiotherapy 1Carboplatin 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Thymoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT05407649 2022-06-07

Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours

Shanghai Cancer Hospital, China

Phase 2 Unknown
60 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡